Baricitinib update

pharmacist with tablet in store
New monograph released to guide safe treatment of serious COVID-19 symptoms The Society of Hospital Pharmacists of Australia has brought forward the release of streamlined information on the safe administration of baricitinib for people with severe COVID-19 symptoms requiring ventilation While baricitinib is approved for the treatment of active rheumatoid arthritis and atopic dermatitis, in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous API acquisition joust not over yet
Next Guild partners for coal industry health